WeVote
Log In

Bill

Bill

HB 1061

PROP TX-CREDIT CARD PAYMENT

104th Regular Session Introduced by Dee Avelar and 1 co-sponsor

HB 1061 aimed to ensure Arkansas Medicaid covers continuous glucose monitors for individuals with gestational diabetes, improving health outcomes for mothers and babies.

Rule 19(a) / Re-referred to Rules Committee
0
WeVote Research Nonpartisan
Bill Summary · HB 1061

Summary of House Bill 1061

Bill Number: HB 1061
Title: To Ensure That Individuals with Gestational Diabetes Are Provided Coverage for Continuous Glucose Monitors Under the Arkansas Medicaid Program
Status: Withdrawn by Author
Introduced: December 10, 2024
Classification: Bill

Purpose and Intent

House Bill 1061 was introduced to amend the Arkansas Medicaid Program to ensure that individuals diagnosed with gestational diabetes receive coverage for continuous glucose monitors (CGMs). The intent of the bill was to improve health outcomes for pregnant individuals managing gestational diabetes by providing them with necessary medical equipment to monitor their blood glucose levels effectively.

Key Provisions

The bill proposed the following key changes to the Arkansas Code § 20-77-148 regarding Medicaid coverage for continuous glucose monitors:

  • Eligibility for Coverage: The Arkansas Medicaid Program would provide coverage for a continuous glucose monitor if the individual has:

    • Gestational Diabetes: Specifically included as a qualifying condition for coverage.
    • Other Conditions: Also included were individuals with type 1 diabetes (with specific criteria) and glycogen storage disease type 1a.

  • Follow-Up Requirement: Individuals receiving coverage for CGMs would be required to have regular follow-up visits with a healthcare provider at least every six months to assess the ongoing benefit of the monitor.

Impact

If enacted, this bill would have had a significant impact on individuals with gestational diabetes in Arkansas by:
- Improving Access to Technology: Ensuring that those affected could access continuous glucose monitoring technology, which is crucial for managing blood sugar levels during pregnancy.
- Enhancing Health Outcomes: Potentially reducing complications associated with gestational diabetes for both the mother and the child.

Legislative Timeline

  • December 10, 2024: Bill filed.
  • January 13, 2025: Bill read for the first time, rules suspended, read a second time, and referred to the Public Health, Welfare and Labor Committee in the House.
  • February 18, 2025: Bill withdrawn by the author.

Conclusion

While HB 1061 aimed to enhance healthcare coverage for individuals with gestational diabetes under the Arkansas Medicaid Program, it was ultimately withdrawn before further legislative action could be taken. The discussion around this bill highlights ongoing concerns regarding access to necessary medical devices for managing chronic conditions during pregnancy.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.